Show Navigation

Image 1 of 1

2021-03-31-Lacen Labs-152.jpg

Add to Lightbox Download
A lab technician holds a sample taken from an RT-PCR test inside the liquid to preserve it for testing at Lacen Central Laboratory March 30, 2021 in Manaus, Brazil. Brazilian residences are receiving the CoronaVac vaccine, also known as the Sinovac COVID-19 vaccine. CoronaVac is an inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech and has been in Brazil's Phase III clinical trials. Photo Ken Cedeno
Copyright
Ken Cedeno
Image Size
5500x3674 / 2.1MB
Contained in galleries
A lab technician holds a sample taken from an RT-PCR test inside the liquid to preserve it for testing at Lacen Central Laboratory March 30, 2021 in Manaus, Brazil. Brazilian residences are receiving the CoronaVac vaccine, also known as the Sinovac COVID-19 vaccine. CoronaVac is an inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech and has been in Brazil's Phase III clinical trials. Photo Ken Cedeno